OMERS recoups cost on Xanadu investment after trimming stake in quantum company
OMERS Ventures sold 3.63 million shares of Xanadu Quantum Technologies, recouping its initial investment. The pension fund remains a major shareholder with 38% of class B shares. Xanadu's stock has lost over half its value since its lockup period ended, closing at $2.94. The company is competing for U.S. government funding to develop a commercial-grade quantum computer by 2033.
How this was made
The 30-second read
Why it matters
The stake reduction reduces OMERS' influence but provides cash for redeployment; the market may react to the increased float and perceived valuation concerns.
Market read
The disclosure adds new information on shareholder composition and potential short-term price impact for Xanadu.
What to watch
Potential upcoming DARPA competition funding and Canadian government support may offset short-term sell pressure.
Background
OMERS Ventures, the venture arm of Ontario's pension fund, has been a long-time backer of Xanadu, a quantum computing developer that went public via a SPAC merger in March.
Market effects
Highlights liquidity risk for quantum computing stocks after lockup expirations.
Limited to Canadian and US tech investors tracking quantum sector.
Modest, as Xanadu is a niche player in the broader quantum computing landscape.
Counterpoint
The sale could be seen as a strategic redeployment, not a lack of confidence, supporting a longer-term bullish view.
Key entities
- InvestorOMERS Ventures
Pension fund venture arm reducing its Xanadu stake.
- CompanyXanadu Quantum Technologies Ltd.
Quantum computing firm listed on Nasdaq.